Boehringer Ingelheim International GmbH;ViraTherapeutics GmbH
发明人:
Philipp MUELLER,Klaus ERB,Patrik ERLMANN,Tobias Friederike NOLDEN,John Edward PARK,Guido WOLLMANN
申请号：
US16751364
公开号：
US20200237838A1
申请日:
2020.01.24
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to the field of oncolytic viruses and in particular to a recombinant rhabdovirus, such as vesicular stomatitis virus encoding in its genome for a CCL21 protein. The invention is further directed to the use of the recombinant virus in the treatment of cancer, and also to methods for producing such viruses.
